Previous close | 37.34 |
Open | 42.00 |
Bid | 41.52 x 200 |
Ask | 41.65 x 100 |
Day's range | 41.36 - 45.41 |
52-week range | 36.73 - 71.85 |
Volume | |
Avg. volume | 1,340,986 |
Market cap | 2.419B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.41 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 72.09 |
Inari Medical's (NARI) first-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the companies continue to incur operating losses.
Q1 2024 Inari Medical Inc Earnings Call
Despite a challenging market, Inari Medical reports significant revenue growth and strategic advancements in international markets.